Healthcare · Biotechnology · NASDAQ
| Market cap | $2.09B |
|---|---|
| Trailing P/E | — |
| FCF yield | -19.1% |
| Revenue growth (YoY) | +48.0% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Agios Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Sep 10, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 7, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jan 12, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | May 6, 2025 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Feb 11, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Feb 15, 2024 |